Subcutaneous rituximab versus intravenous rituximab – safety and efficacy results
Advances in AML understanding: APL therapy, immunotherapy and maintenance therapy
Alan Burnett et al.
Highlights from ASH 2016: adaptive therapy and reducing toxicity
Current news in MCL - allogeneic transplants
Reinforcing transplantation with consolidation therapy in Hodgkin lymphoma